...
【24h】

Acute coronary syndrome: evidence-based practice in action.

机译:急性冠状动脉综合征:循证实践。

获取原文
获取原文并翻译 | 示例
           

摘要

ACUTE CORONARY SYNDROME (ACS) is a heading for three smaller classes of ischemic myo-cardial disease: ST-segment elevation myocardial infarction (STEMI), unstable angina (UA), and non-ST-segment elevation myocardial infarction (NSTEMI). Despite variation, each leads to a sudden decline in the blood flow to the myocardial cells. Coronary artery disease (CAD) negatively impacts approximately 15 million people in the United States, resulting in a cost of more than 71.2 billion dollars for inpatient treatment. Increases over the next 20 years in CAD-related deaths are estimated by the World Health Organization as 137%inmenand 120% in women. Large multisite research trials have led to the development of evidence-based practice recommendations by the American Heart Association (AHA) and the American College of Cardiology (ACC) for the medical and pharmacologic management of patients experiencing any of the three entities found under the heading of ACS.
机译:急性冠状动脉综合征(ACS)是缺血性心肌病的三种较小类别:ST段抬高型心肌梗塞(STEMI),不稳定型心绞痛(UA)和非ST段抬高型心肌梗塞(NSTEMI)。尽管有差异,但每种都会导致流入心肌细胞的血流量突然下降。在美国,冠状动脉疾病(CAD)负面影响了大约1500万人,导致住院治疗的费用超过712亿美元。据世界卫生组织估计,未来20年与CAD相关的死亡人数将增加137%,女性增加120%。大型的多站点研究试验已经导致美国心脏协会(AHA)和美国心脏病学会(ACC)制定了基于证据的实践建议,以对经历以下标题下的三个实体中的任何一个的患者进行医学和药理管理ACS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号